Back to Trials
NCT06654713Recruiting

Commercial or Open Source Closed Loop Impact on Pregnancy Study

University of California, San Francisco

Start Date

3/13/2025

Completion Date

12/31/2029

Summary

The goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems. The main questions this study aims to answer are: * What are the maternal and neonatal outcomes with AID system use in pregnancy? * What are the glycemic outcomes with AID system use in pregnancy? * What are the behavioral and emotional outcomes with AID system use in pregnancy? Researchers will compare pregnant people who use commercial AID systems and pregnant people who use open source AID systems to see if outcomes are different with these different types of systems. Participants will be asked to remotely share their AID system data with the research team; complete online surveys regarding behavioral and emotional health; and sign an authorization to release health information to allow the research team to access medical records.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion criteria: * Pregnant * Diagnosis of type 1 diabetes (T1D) prior to pregnancy * Active use of automated insulin delivery (AID) system Exclusion criteria: * Diagnosis of other forms of diabetes (gestational diabetes, type 2 diabetes, monogenic diabetes)

Interventions

OTHER

Commercial AID system

OTHER

Open source AID system

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Type 1 DiabetesPregnancy, High RiskInsulin Dependent DiabetesPregnancy Related

Locations

University of California, San Francisco

San Francisco, California 94158

United States